Testosterone Cypionate Reviews: What the Ratings Actually Measure

---

Short answer: testosterone cypionate reviews are real, but many of the biggest ratings are not measuring testosterone cypionate alone. Major review pages pool gels, pills, pellets and several injections into one testosterone score. A separate Depo-Testosterone page is cypionate-specific, but it has only ten ratings.

FDA-approved testosterone cypionate products exist, including Depo-Testosterone and approved generics. Whether treatment makes sense depends on a proper diagnosis, fertility plans, health risks, and the exact product a pharmacy will dispense. The AUA says diagnosis requires symptoms or signs plus consistently low testosterone confirmed on two separate early-morning measurements.¹

There is one word sitting on one of those big review pages that proves the pooling problem in about ten seconds. We will show you exactly where it is.

---

Is cypionate usually a reasonable option?

It may be worth discussing with a clinician if: your testosterone was confirmed low on two separate early-morning blood tests, you have symptoms or signs that match, fertility is not an immediate goal, and an injectable treatment format fits your preferences. Testosterone cypionate is often inexpensive as a prescription drug, but the total cost depends much more on visits, testing, monitoring, pharmacy choice and insurance.

Look at another care route first if: you are trying to conceive, you have not had a proper diagnostic workup, or you have a condition that needs in-person evaluation before testosterone is considered. The current Depo-Testosterone label lists breast cancer, known or suspected prostate cancer, serious cardiac/hepatic/renal disease and hypersensitivity among its contraindications; it also says testosterone products are not recommended for patients with uncontrolled hypertension.²

---

This page is educational information, not medical advice. It cannot tell you whether testosterone is right for you. If you have chest pain, sudden shortness of breath, or pain and swelling in one leg, get emergency care now. Do not finish reading first.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

---

What we actually verified

Checked on 18 September 2026. We read the primary and live sources below rather than relying on other affiliate articles.

Primary and official sources read directly:

• The current DailyMed record for Depo-Testosterone (SPL version 26; DailyMed updated 21 August 2026; the embedded Pfizer prescribing information still says “Revised September 2025”)²
• The FDA's class-wide testosterone labeling statement of 28 February 2025³
• The HHS/FDA announcement of 18 June 2026 requesting further testosterone labeling updates⁴
• The American Urological Association guideline on testosterone deficiency¹
• The AUA/ASRM male infertility guideline, amended 2024⁵
• The current FDA/DailyMed label for Xyosted (testosterone enanthate)⁶
• The DEA/HHS Fourth Temporary Extension of telemedicine flexibilities through 31 December 2026⁷
• The ASHP/University of Utah testosterone cypionate shortage bulletin updated 5 March 2026⁸

Live pages read directly:

• Drugs.com testosterone and Depo-Testosterone review pages⁹¹⁰
• WebMD's pooled testosterone review page¹¹
• Hone Health's testosterone cypionate product page and September 2026 membership/help pages¹²¹³
• Male Excel's current cypionate, pricing, FAQ and homepage disclosures¹⁴¹⁵¹⁶
• Taurus Meds' current TRT offer and terms¹⁷¹⁸

What we confirmed: the current public review counts and ratings shown below; the exact contents and labeling status of Depo-Testosterone; the February 2025 FDA class-wide labeling action; the June 2026 requested labeling updates; the current federal telemedicine extension; and each provider's published price/formulation statements.

What is provider-stated, not independently verified by us: provider prices, service inclusions, pharmacy fulfillment, state coverage, refund promises, treatment claims and outcomes. We report those as company statements, not as proof that every patient receives the same thing.

What we could not confirm for an individual reader: the exact product or pharmacy they would receive, whether a provider serves their state at the moment they apply, what insurance will pay, and live pharmacy stock on a given day.

The right next step is not the same for everyone

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

---

Are these reviews actually about testosterone cypionate?

Mostly, no. The largest testosterone review pages combine more than twenty brand names and every form of the drug into a single average, so the rating reflects gels and pills as much as injections. The clearest cypionate-specific Drugs.com page is built on only ten total ratings, and the hypogonadism-specific subset contains nine written reviews. That is useful experience evidence, but it is a tiny sample compared with the pooled testosterone page.⁹¹⁰

Here is what we found when we checked each source on 18 September 2026.

The one-word proof

Drugs.com publishes a list of the ten side effects mentioned most often in its testosterone reviews. One of the side-effect terms surfaced on Drugs.com's pooled testosterone comparison data is "smell."¹⁹

The Depo-Testosterone label describes testosterone cypionate itself as odorless or nearly so and the product as an intramuscular oil solution.² "Smell" therefore cannot be treated as evidence about cypionate injections specifically. The important point is not why any one reviewer mentioned it; the important point is that the pooled score includes products and delivery forms other than cypionate injection.

That single word tells you the 7.3 is not a cypionate score. Go look at it yourself. It takes ten seconds.

What a 9.9 out of ten people is worth

Not much, and not because those ten men are lying.

Ten ratings is a sample size where one very different rating can move the average by nearly a full point. A 100% positive, 0% negative page almost never means a drug is perfect. It usually means people who had a bad time did not come back to post. The newest of those ten reviews was written in 2023. Nothing from 2024, 2025 or 2026.

Six questions that tell you if a review is worth anything

Use this on any testosterone review you read, anywhere:

1. Does it name the exact product? "Testosterone" is not an answer. Cypionate, enanthate, gel and pellets behave differently.
2. Does it say which route and schedule were prescribed? Different labeled and off-label schedules can produce different peak-and-trough patterns, so a review without that context is hard to interpret.
3. Was low testosterone actually confirmed? If the review does not say, do not assume the writer met current diagnostic standards.
4. How long were they on it? An early impression and a months-long treatment experience answer different questions.
5. Did anything else change at the same time? New gym routine, weight loss, a thyroid medication, quitting drinking.
6. Is the reviewer selling anything? Including a program, a coupon code, or a clinic.

A review that answers four or more of those is genuinely useful. Most answer one.

---

What do the reviews say — and does the evidence back it up?

Across the review corpus, the most common praise is for energy, mood, mental clarity and sex drive. The most common complaints are injection pain, feeling flat before the next dose, acne, and testicular shrinkage. The catch is that four of the most-praised benefits are precisely the ones the American Urological Association says the evidence is inconclusive about.

That is not a gotcha. It is the single most useful thing on this page, so read the table slowly.

Here is the honest reading, and we want to be careful with it.

This does not mean those men are lying or imagining things. It means the outcomes that are easiest to feel are the hardest to prove in a trial. Energy and mood are subjective, they respond strongly to expectation, and they move for a dozen reasons at once. The outcomes that are easier to measure — sexual function, lean mass, bone density — show up more consistently in the research and, oddly, get mentioned less in reviews.

So read the five-star reviews with that asymmetry in mind. A man saying "I got my life back" is telling you something true about his experience. He is not telling you what will happen to you.

---

What does the FDA label for testosterone cypionate actually say?

Testosterone cypionate is FDA-approved for two things: primary hypogonadism and hypogonadotropic hypogonadism. Those are low-testosterone conditions caused by a problem with the testicles or with the brain signals that drive them. The label also tells prescribers to confirm the diagnosis with morning blood tests on at least two separate days before starting.

Let us define a couple of terms, because they matter later.

• Hypogonadism just means the body is not making enough sex hormone.
• Primary means the problem is in the testicles. Hypogonadotropic (also called secondary) means the problem is in the pituitary gland or hypothalamus in the brain, which send the signals.
• FDA-approved means the FDA reviewed that exact product for safety, effectiveness and manufacturing quality. Compounded means a pharmacy mixed it for a specific patient. Compounded products are legal and sometimes necessary, but the FDA does not review them.

What is actually in the vial

Almost no review page mentions this, and it can rule the drug out for some men.

If you have a cottonseed allergy, cypionate is a problem. Testosterone enanthate uses sesame oil instead. That is a one-sentence fact that can save someone a very unpleasant week, and we have not found it on a single competing review page.

Did the FDA remove the heart warning? Yes — and then it went further

This is where a lot of what you will read online is flatly wrong, including on pages currently ranking for this topic. Several of them say the FDA added a cardiovascular boxed warning in 2024 or 2025. The FDA did close to the opposite. Here is the actual sequence.

28 February 2025. After reviewing the TRAVERSE trial and required blood-pressure studies, the FDA told testosterone manufacturers to make class-wide labeling changes. It recommended adding the TRAVERSE results to all testosterone labels, keeping the "Limitation of Use" language about age-related low testosterone, and removing boxed-warning language about increased cardiovascular risk. Separately, it required adding blood-pressure information and a new blood-pressure warning where one did not already exist.

18 June 2026. HHS, through the FDA, went further and requested three more changes: remove the limitation of use saying safety and effectiveness have not been established in men with age-related low testosterone; update the prostate cancer information, narrowing the contraindication toward metastatic disease while keeping screening and monitoring recommendations; and revise the enlarged-prostate warnings to reflect evidence that mild to moderate cases did not worsen on treatment.

Now here is the part nobody has written about

We read the current Depo-Testosterone DailyMed record on 18 September 2026. DailyMed lists SPL version 26 as current and says the record was updated 21 August 2026, while the embedded Pfizer prescribing information still says “Revised September 2025.” Two things are true at the same time:²

✅ The required change is there. The WARNINGS section now says testosterone can raise blood pressure, which can increase cardiovascular risk over time; that blood pressure should be monitored periodically, especially in men who already have high blood pressure; and that testosterone products are not recommended for men with uncontrolled hypertension.

❌ The recommended change is not. The same section still says that long-term clinical safety trials on cardiovascular outcomes have not been conducted, and describes the existing evidence as inconclusive. TRAVERSE is not mentioned anywhere in the label.

That asymmetry makes sense once you see it: the FDA required the blood-pressure language and only recommended the TRAVERSE addition. The required half landed. The recommended half has not, at least not on this product. And the June 2026 requests are newer than the label, so none of those appear either.

What that means for you in plain terms: the paper folded up inside your box may describe a regulatory position that the FDA has since asked to change twice. It is not wrong to read it. It is just behind. And if you are reading reviews written in 2014 or 2019, those men were making decisions under an even older set of warnings than the one in your box.

One more thing about TRAVERSE that almost nobody says out loud

TRAVERSE followed more than 5,200 men receiving AndroGel 1.62% or placebo. FDA reports major adverse cardiovascular events in 7.0% of the testosterone group and 7.3% of the placebo group and said the trial did not demonstrate a new cardiovascular safety signal. Those results helped drive the FDA's 2025 labeling action.²⁰

TRAVERSE studied transdermal testosterone — a gel. Not cypionate. The FDA applied its findings across the whole class, which is a normal regulatory judgment. But when someone tells you "a huge trial proved cypionate is safe for your heart," the precise version is that a huge trial of a testosterone gel led regulators to reconsider the class-wide warning that also covers cypionate. Both facts are true. Only one of them usually gets said.

---

What are the real side effects of testosterone cypionate?

The FDA label lists breast tissue growth, acne, prolonged erections, reduced sperm production at higher doses, fluid retention, raised red blood cell counts, mood changes, injection-site pain, and rare clotting and eye problems — with no frequency attached to any of them. Reviewers most often report injection-site soreness, acne, testicular shrinkage, and a noticeable drop in how they feel in the days before the next dose.

That gap is worth naming directly. The cypionate label is an older-style document. It has no percentage table and no placebo column, which means there is no official number for how often any of this happens. That is a large part of why men end up reading reviews in the first place. The label cannot answer the question, so they go looking for someone who can.

What the label actually lists

• Hormonal and urinary: breast tissue enlargement, erections that are too frequent or last too long, reduced sperm count at higher doses
• Skin and hair: increased body hair, male-pattern hair loss, oily skin, acne
• Heart and circulation: heart attack, stroke, and blood clots in veins including the legs and lungs
• Fluid and salts: retention of sodium, water, potassium, calcium and other electrolytes
• Stomach and liver: nausea, jaundice, changes in liver test results, and rarely liver growths
• Blood: suppression of certain clotting factors, bleeding in people on blood thinners, and polycythemia — too many red blood cells, which thickens the blood
• Nervous system: higher or lower sex drive, headache, anxiety, depression, tingling sensations
• Allergic: hypersensitivity reactions including severe ones
• Eyes: rare cases of central serous chorioretinopathy, a fluid buildup under the retina
• Injection site: inflammation and pain

What monitoring is supposed to catch

The cypionate label says hemoglobin and hematocrit should be checked periodically during long-term treatment. Hematocrit is the percentage of your blood made up of red blood cells. Testosterone can push it up, and thick blood raises clot risk. It also notes that cholesterol can rise.

For comparison, the newer label for Xyosted — an FDA-approved weekly testosterone enanthate autoinjector — is more specific and says to monitor hematocrit roughly every three months. That is a useful benchmark to bring to a conversation about monitoring, whichever product you end up on.

Symptoms that need urgent medical attention

Chest pain or sudden shortness of breath can be medical emergencies. Pain, swelling, warmth or redness in one leg can be a sign of a blood clot and needs prompt evaluation. New or worsening breathing problems during sleep and a prolonged erection also need medical attention. Follow the emergency instructions from your clinician and local emergency services rather than using this page to decide how serious a symptom is.²

Why some reviews describe a late-interval “crash”

Cypionate has an intramuscular half-life of about eight days, and the FDA label allows replacement dosing at intervals of two to four weeks.² An older pharmacokinetic study of 200 mg intramuscular cypionate every two weeks found high levels in the first several days followed by a decline toward baseline by days 13 to 14.²¹

That helps explain why older reviews written under longer injection intervals can describe a very different experience from reviews written under newer off-label schedules. It does not tell you what schedule you should use. Frequency and route are prescribing decisions for the clinician managing the treatment.

---

Why might your prescribed schedule not match the cypionate label?

The current Depo-Testosterone label is intramuscular only and allows 50–400 mg every two to four weeks for replacement in a hypogonadal male. Some clinicians prescribe different frequencies or use subcutaneous cypionate off-label. “Off-label” means the clinician is using an FDA-approved drug in a way that is not the labeled route or schedule; it is not the same thing as an unapproved drug.²

Evidence for subcutaneous use exists, but it is not identical to a cypionate label approval. A small study in transgender patients found stable testosterone concentrations with weekly subcutaneous cypionate, while other studies have evaluated subcutaneous testosterone enanthate.²² Those data can support a clinician's off-label judgment; they are not instructions to change route or frequency yourself.

If your vial says intramuscular and your clinician prescribed another route or schedule, ask why. The useful question is whether the choice is deliberate, evidence-informed and monitored—not whether an internet review used the same routine.

Will you get the FDA-approved drug or a compounded version?

Not every product sold as "testosterone cypionate" is the FDA-approved drug. Some online programs dispense a compounded preparation made by a compounding pharmacy, which the FDA has not reviewed for safety or effectiveness. They are not the same regulatory category, and you should know which one is being proposed before you pay. FDA-approved finished products are reviewed through the drug-approval process; compounded drugs are not FDA-approved.

This is the most consequential paragraph on this page, so let us be precise and fair about it.

Compounding can have a legitimate role when a prescriber determines that an FDA-approved product does not meet a patient's clinical need. But compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness or manufacturing quality before marketing in the same way it does approved products. The practical problem for a buyer is not just whether a product is compounded; it is whether the clinic clearly tells you what product and pharmacy are involved.

So we checked. Here is what each provider's own public pages say, read on 18 September 2026.

Credit where it is due: Hone puts that disclosure on the product page itself, underneath the price. A lot of companies bury it in a terms document or leave it out. That is the behavior you want to see.

A note on language. Several providers use the word "bioidentical." It is a marketing term, not a regulatory one, and it does not tell you whether a product is FDA-approved. We report it when a company uses it. We do not use it ourselves, and neither should you when you are trying to work out what is in the box.

On Male Excel specifically: the current site now states that its testosterone is compounded in the United States and names pharmacy partners. That is clearer than a bare product description, but it still does not identify the exact product, strength and pharmacy that every patient will receive.¹⁶

Three questions that settle it in one message

Send these to any provider, in writing, before your card is charged:

1. "Is the testosterone cypionate you will dispense to me an FDA-approved manufactured product, or a compounded preparation?"
2. "Which pharmacy fills it, and what is the manufacturer and NDC number if it is a manufactured product?"
3. "What concentration and vial size will I receive, and what route and schedule is being prescribed?"

A provider that answers all three plainly is showing you something important about how they operate. One that will not is also telling you something.

---

If you are still working out whether an injection, a cream, or a non-testosterone route even fits your situation, that is the question to settle before you compare prices.

→ Map your care route with Find My TRT Path — it walks through your symptoms, testing status, state, fertility plans and budget, and gives you the questions to ask before you pay. It is educational and non-diagnostic. It does not confirm low testosterone or guarantee a prescription.

---

Does testosterone cypionate affect fertility?

Yes, and this needs settling before treatment, not after. Exogenous testosterone suppresses the brain signals that support testicular testosterone production and spermatogenesis. The amended AUA/ASRM male infertility guideline states that clinicians should not prescribe exogenous testosterone therapy to a male interested in current or future fertility.⁵

Here is the mechanism in plain language. Your brain sends two hormones to your testicles — LH (luteinizing hormone), which tells them to make testosterone, and FSH (follicle-stimulating hormone), which drives sperm production. When you inject testosterone, your brain reads the high level and turns both signals down. Testosterone production stops. Spermatogenesis — sperm production — slows or stops with it.

The cypionate label says the same thing in its own words: at large doses, sperm production may be suppressed through this feedback loop, and reduced sperm count can occur after prolonged use or excessive dosage.

The AUA's testosterone guideline makes discussing this a Strong Recommendation backed by Grade A evidence — its highest tier. That is not a footnote. That is the guideline telling clinicians this conversation is mandatory.

What we will not tell you: that testosterone will definitely make you infertile, that it definitely will not, that stopping restores fertility on any particular timeline, or that any add-on medication protects it. Recovery is genuinely variable and nobody can promise you a number.

What we will tell you: if you are actively trying to conceive or planning family-building in the near future, start with a urologist, reproductive urologist, endocrinologist or another fertility-aware clinician rather than treating a general online TRT program as the default. This belongs with a urologist, a reproductive urologist, or an endocrinologist who handles fertility. Some clinics do offer medications aimed at preserving the signal. Those are not interchangeable with standard testosterone therapy, they are a different conversation, and they need someone who does this work regularly.

---

If fertility is on the table for you, that changes your best next step — and it is not a general online program.

→ Use Find My TRT Path to route to fertility-aware care — it will point you toward the right kind of clinician and give you the specific questions to bring.

---

Why can't your pharmacy get it?

Testosterone cypionate injection remains listed in an ASHP shortage bulletin updated 5 March 2026, and availability varies by manufacturer and package. The bulletin lists some products as available while Pfizer's Depo-Testosterone and certain Eugia presentations remain constrained.⁸

Per the drug shortage bulletin maintained by the University of Utah Drug Information Service and distributed by ASHP, updated 5 March 2026:

Shortage status changes month to month. Check the FDA's drug shortage database for the live picture before assuming anything.

There is a quiet irony in that table worth naming. The brand-name Depo-Testosterone products were listed on shortage in the March 2026 bulletin, while Hikma and Padagis products were listed as available. That is another reason not to assume a Depo-Testosterone review describes the exact manufacturer a pharmacy will dispense to you.⁸

If your pharmacy is out: contact the pharmacy and prescriber rather than changing concentration, product or schedule on your own. The current ASHP bulletin lists alternative testosterone dosage forms as options clinicians may consider during shortage conditions.⁸

Online programs may use different pharmacy supply channels, including compounding pharmacies, so their inventory can differ from a local retail pharmacy. That does not guarantee availability, and it loops directly back to the formulation question above.

---

What does testosterone cypionate actually cost?

The medication price and the cost of TRT care are not the same thing. A retail prescription may be inexpensive for some people, while an online program adds testing, clinician access, monitoring and membership fees. Because cash prices and insurance benefits vary by pharmacy, plan, location, vial size and manufacturer, we do not publish one national retail-drug price as though it applies to everyone.

We recalculated the three online examples below from current provider-stated figures checked 18 September 2026. These are published-price baselines, not guaranteed quotes.

Math: Male Excel = $99 + ($99 × 12) + ($120 × 12) = $2,727, before shipping. Hone Plus with at-lab confirmation = $45 + $45 + ($135 × 12) + ($28 × 12) = $2,046. Taurus = $49 + ($149 × 12) = $1,837. These totals use starting/provider-stated prices and do not account for individualized dose changes, taxes, outside pharmacy charges or services not included in the cited offer.¹³¹⁵¹⁷

Read that table carefully, because the totals are not apples to apples. Male Excel's advertised injectable bundle includes thyroid medication. Hone Plus separates membership and medication and has a specific confirmatory-testing step. Taurus publishes the lowest simple baseline of the three, but its public page is less itemized than the other two. A lower total is not automatically a better deal, and a higher one is not automatically a rip-off.

The part most sites in this space will not put in writing

Here it is, plainly.

You are not paying an online program only for testosterone. You are paying for some combination of testing, clinician access, prescription management, monitoring, fulfillment and convenience. If you already have a clinician who will evaluate you properly and prescribe through a pharmacy you choose, compare that route before paying for a subscription.

Male Excel is a cash-pay model. Its current pricing page lists a $99/month medical membership and injectable treatment starting at $120/month, plus shipping, and says its approach is not covered by insurance.¹⁵ If your priority is the lowest possible out-of-pocket cost, price your own clinician + pharmacy route first.

The trade-off is access and structure. Male Excel says its membership includes unlimited messaging and e-visits and that its program uses daily cypionate injections; those are provider-stated program features, not a medical recommendation from us.¹⁵ For someone whose existing clinician will not manage TRT or whose preferred care route is telehealth, that convenience can be what they are paying for.

Does that sound like your situation? You want an online evaluation and ongoing monitoring in one place, and you understand that the provider still has to determine whether treatment is appropriate.

Affiliate disclosure: TRT Provider Guide has affiliate relationships with Male Excel and Taurus Meds. Commercial relationships do not change which care route we describe as the better fit. The links below go to the providers' current public pages.

→ See Male Excel's current pricing and what's included — and confirm the exact compounded product, pharmacy, shipping and first-year bill before paying.

→ See Hone Health's current cypionate pricing — its product page clearly states that the listed cypionate is compounded and not FDA-approved.¹²

→ See Taurus Meds' current program pricing — the lowest simple published baseline of these three, with less public itemization than the other two.¹⁷

How do you actually get testosterone cypionate?

There are three common care routes: a clinician using your insurance, a clinician with a cash prescription filled at a retail pharmacy, or an online program that bundles some combination of evaluation, medication and monitoring. Which route costs less or moves faster depends on your insurance, pharmacy, state, testing needs and the provider's process.

Testosterone is a Schedule III controlled substance in the United States. That means it has recognized medical use and a moderate potential for abuse, and it always requires a valid prescription. There is no lawful way around that, and anyone implying otherwise is not someone you want handling your bloodwork.

Find yourself in this table

On the diagnosis, since everything else depends on it

The AUA guideline uses a total testosterone level below 300 ng/dL as a reasonable supporting cutoff. Three things about that number matter more than the number itself.

• It is a supporting cutoff, not a verdict. The guideline is explicit that a clinical diagnosis requires low levels and matching symptoms or signs.
• It needs two separate early-morning draws, ideally at the same lab using the same method. Testosterone swings through the day and peaks in the early morning. That recommendation carries the guideline's strongest evidence grade.
• It is not a universal self-diagnosis number. The AUA uses it as a reasonable cutoff in support of diagnosis; symptoms/signs and repeat testing still matter.¹

We cannot interpret your labs and neither can a website quiz. What we can tell you is what a properly done evaluation looks like, so you can tell whether you got one.

One thing worth knowing about timing

The federal telemedicine rule is still temporary. DEA and HHS extended the pandemic-era telemedicine flexibilities for prescribing controlled medications through 31 December 2026. Under the extension, a DEA-registered practitioner may prescribe Schedule II–V controlled medications through qualifying telemedicine without a prior in-person medical evaluation, provided the prescription otherwise complies with DEA rules and applicable federal and state law.⁷

That does not mean every TRT clinic can prescribe testosterone in every state or that an in-person exam can never be required. State licensure, state prescribing rules, the clinician's authority, and the provider's own process still apply. Because this rule is time-limited, verify the current federal and state requirements if you are acting after December 31, 2026.

Cypionate versus the other options

Testosterone cypionate is a long-acting injectable with an intramuscular half-life of about eight days. Other FDA-approved testosterone products use different esters and delivery systems, including gels, subcutaneous enanthate autoinjectors, oral testosterone undecanoate and pellets. They differ in labeling, practical trade-offs and cost, so a review of one format should not be treated as a review of all testosterone therapy.²

One detail from that table is worth pulling out because older summaries can get it wrong. Xyosted is not currently contraindicated solely because a man has age-related hypogonadism. Its current label says safety and efficacy in that population have not been established; FDA removed the age-related-hypogonadism contraindication from the Xyosted label in 2025.⁶ Depo-Testosterone currently carries similar “not established” limitation language.²

For a deeper side-by-side of who dispenses what, see our best testosterone cypionate providers comparison.

---

How long does testosterone cypionate take to work?

There is no single review-based timeline you can safely apply to yourself. Different outcomes are measured on different timelines, people start from different baseline levels and causes, and the prescribed product, route and schedule also differ. A dramatic early review is an anecdote, not a dosing target or a promise.

A useful way to read timing claims is to separate blood levels from clinical outcomes. Intramuscular cypionate reaches high levels after injection and then declines over the dosing interval; older pharmacokinetic data show that clearly.²¹ But feeling better, changing sexual symptoms, correcting anemia or changing body composition are separate outcomes with different evidence and time courses.

Follow-up labs matter because treatment is not judged by symptoms alone. A clinician may monitor testosterone, hematocrit and other patient-specific markers to judge response and safety. The AUA recommends baseline hemoglobin/hematocrit before therapy and ongoing monitoring based on treatment and risk.²³

If symptoms do not improve despite appropriate treatment and follow-up, that is information to take back to the clinician. It may mean the symptoms have another cause or that the treatment plan needs reassessment. It is not a reason to increase a dose on your own.

Who should not start testosterone cypionate online

Some situations need more than a questionnaire or mailed lab kit before testosterone is considered. The right setting depends on the condition, state rules and the clinician's judgment, but complex risk belongs with a clinician who can do the needed examination and workup.

That includes known or suspected prostate cancer, male breast cancer, uncontrolled high blood pressure, serious heart/liver/kidney disease, elevated hematocrit, untreated severe sleep apnea, concerning PSA/prostate findings, or active near-term fertility plans. Some are contraindications in product labeling; others require further evaluation or specialist input.²²³

It also includes anything that suggests a cause worth finding rather than a level worth topping up — unexplained weight loss, vision changes, headaches with low testosterone, very low levels in a young man, or testicular pain or lumps. Those point toward the pituitary gland or the testicles and belong with an endocrinologist or urologist.

And one population note. Everything on this page is about adult men being evaluated for testosterone deficiency. If you are looking for information about testosterone for women, for anyone under 18, for gender-affirming care, or for athletic or bodybuilding use, this is the wrong framework and the wrong guidelines. We do not publish dosing, cycling or acquisition guidance, and we would rather send you somewhere appropriate than half-answer you.

If you recognized yourself in any of the above, Find My TRT Path will point you toward the right kind of clinician instead.

---

How we researched this page

We separated four different kinds of evidence instead of blending them, which is the core of our documented method, How We Review TRT Providers.

• Verified fact — something we read ourselves in a primary source or on a live page, with the date recorded.
• Provider-stated fact — something a company publishes about itself, reported as its claim.
• Customer-experience signal — patterns in what patients report, useful for understanding experience, never used to establish that a medication is safe, effective or appropriate.
• Editorial conclusion — our judgment, built from the verified facts above and labeled as judgment.

For this page we added a step we do not normally need: a review-source audit. Because the keyword is about a medication rather than a company, we had to establish what the existing ratings actually measure before we could responsibly report them.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy care. We are not a clinic, pharmacy, laboratory, manufacturer, insurer or medical practice. Provider inclusion does not mean endorsement, and commercial relationships do not establish clinical quality.

---

Frequently asked questions

Is testosterone cypionate well reviewed? Patient review sites contain many positive reports, but the published aggregate ratings usually mix several different testosterone products together. They should not be read as a cypionate-specific success rate.

Is testosterone cypionate the same as Depo-Testosterone? Depo-Testosterone is the brand name for testosterone cypionate injection. There are also FDA-approved generics from manufacturers including Hikma and Padagis, and some clinics dispense compounded testosterone cypionate, which is a separate category. Check which one you are getting.

Is testosterone cypionate FDA approved? Yes. FDA-approved testosterone cypionate products exist and are approved for primary hypogonadism and hypogonadotropic hypogonadism. Compounded testosterone cypionate is not FDA-approved and should never be described as though it is.

Does the FDA still warn that testosterone causes heart attacks? The picture changed. In February 2025 the FDA recommended removing boxed-warning language about increased cardiovascular risk and required new blood-pressure warnings. In June 2026 HHS and the FDA requested further changes, including removing the limitation of use for age-related low testosterone. The current cypionate label carries the blood-pressure warning but has not yet been updated with the trial results.

Does testosterone cypionate raise blood pressure? The FDA concluded from required ambulatory blood-pressure studies that testosterone products can raise blood pressure, and it required class-wide labeling updates. The current cypionate label says to monitor blood pressure periodically and that these products are not recommended for men with uncontrolled hypertension.

Is testosterone cypionate a controlled substance? Yes. Testosterone is Schedule III in the United States and requires a valid prescription.

Can testosterone cypionate affect fertility? Yes. Injected testosterone suppresses the brain signals that drive sperm production. The AUA/ASRM guideline says testosterone alone should not be prescribed to a man interested in current or future fertility. Recovery after stopping is variable and cannot be promised.

Is weekly injection normal if the label says every two to four weeks? It is very common, and it is off-label. Many clinicians dose weekly specifically to reduce the rise and fall that the longer interval produces. Ask your prescriber why they chose your schedule.

Can I inject it under the skin instead of into the muscle? The cypionate label says intramuscular only, so subcutaneous use is off-label. It is widely practiced and supported by published studies showing comparable levels at the same weekly dose. That is a decision for your prescriber, not something to change on your own.

Why can't my pharmacy get it? Injectable cypionate has been in intermittent shortage since 2023. Availability varies by manufacturer and by pharmacy. You can transfer your prescription, ask about the other concentration, or ask your prescriber about enanthate.

Can I use it if I'm allergic to cottonseed? Raise it with your prescriber before you start. Testosterone cypionate is dissolved in cottonseed oil. Testosterone enanthate uses sesame oil instead.

Does insurance cover testosterone cypionate? Coverage varies by plan, diagnosis, product, pharmacy and prior-authorization rules. Check the actual formulary and benefit rather than assuming that a testosterone cypionate prescription or an online TRT program will be covered.

Is 300 ng/dL automatically low testosterone? No. The AUA describes it as a reasonable supporting cutoff. A clinical diagnosis also requires matching symptoms or signs and two separate early-morning measurements.

Do I have to stay on it forever? Not necessarily. Exogenous testosterone suppresses the body's own signaling while treatment is ongoing, and what happens after stopping varies by the reason for treatment and the individual. Plan any change with the clinician managing your care rather than using a review timeline as a guide.

---

Still not sure which TRT care route fits you?

Reviews can tell you how a medication felt for someone else. They cannot tell you whether your diagnosis was done properly, whether your state allows the care you are looking at, what your fertility plans should change, or what you will actually be shipped.

Use our free Find My TRT Path tool to map your situation to the right care route and get the specific questions to ask before you pay. It is educational and non-diagnostic — it does not confirm low testosterone, determine medical eligibility, or guarantee a prescription.

---

TRT Provider Guide is the independent decision resource for testosterone replacement therapy care. We are not a clinic, pharmacy, laboratory, drug manufacturer, insurer or medical practice. This page is educational information and is not a substitute for care from a licensed clinician. Prices, availability, shortage status and telemedicine rules change; every dated claim reflects what we verified on 18 September 2026.

Sources

• 1. American Urological Association — Evaluation and Management of Testosterone Deficiency
• 2. DailyMed — Depo-Testosterone (testosterone cypionate) current label
• 3. FDA — Class-wide labeling changes for testosterone products, February 28, 2025
• 4. HHS — Requested testosterone therapy labeling updates, June 18, 2026
• 5. AUA/ASRM — Diagnosis and Treatment of Infertility in Men, amended 2024
• 6. DailyMed — Xyosted (testosterone enanthate) current label
• 7. DEA — Fourth Temporary Extension of telemedicine flexibilities through December 31, 2026
• 8. ASHP — Testosterone Cypionate Injection shortage bulletin, updated March 5, 2026
• 9. Drugs.com — Testosterone reviews
• 10. Drugs.com — Depo-Testosterone reviews
• 11. WebMD — Testosterone (Depo-Testosterone, Xyosted, and others)
• 12. Hone Health — Testosterone Cypionate Injections
• 13. Hone Health — Plus Membership, updated September 2026
• 14. Male Excel — Testosterone Cypionate Injections
• 15. Male Excel — TRT pricing
• 16. Male Excel — FAQ
• 17. Taurus Meds — TRT offer
• 18. Taurus Meds — Terms of Use
• 19. Drugs.com — pooled testosterone side-effect terms
• 20. FDA — Testosterone Information and TRAVERSE summary
• 21. Hormone kinetics after intramuscular testosterone cypionate — PubMed
• 22. Serum Testosterone Concentrations Remain Stable Between Injections in Patients Receiving Subcutaneous Testosterone — PubMed
• 23. AUA guideline statements on hematocrit, counseling and monitoring

Sources: FDA prescribing information for Depo-Testosterone (DailyMed); FDA class-wide testosterone labeling statement, 28 February 2025; HHS/FDA announcement on testosterone labeling updates, 18 June 2026; FDA/DailyMed prescribing information for Xyosted; American Urological Association testosterone deficiency guideline; AUA/ASRM male infertility guideline; ASHP/University of Utah drug shortage bulletin for testosterone cypionate injection; DEA/HHS Fourth Temporary Extension of telemedicine flexibilities; Drugs.com and WebMD review pages; and current Hone Health, Male Excel and Taurus Meds published pages.

---

---